{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:52:57Z","timestamp":1786981977417,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11596-018-1854-9","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T02:21:02Z","timestamp":1521080462000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK, p-p38 and the p-ERK\/MAPK Signaling Pathway"],"prefix":"10.1007","volume":"38","author":[{"given":"Hong-yun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-jin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-qing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"issue":"2","key":"1854_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/GRF.0000000000000027","volume":"57","author":"DM Harper","year":"2014","unstructured":"Harper DM, Demars LR. Primary strategies for HPV infection and cervical cancer prevention. Clin Obstet Gynecol, 2014, 57(2): 256\u2013278","journal-title":"Clin Obstet Gynecol"},{"issue":"7","key":"1854_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/OGX.0000000000000089","volume":"69","author":"DR Roque","year":"2014","unstructured":"Roque DR, Wysham WZ, Soper JT. The surgical management of cervical cancer: an overview and literature review. Obstet Gynecol Surv, 2014, 69(7): 426\u2013441","journal-title":"Obstet Gynecol Surv"},{"issue":"15","key":"1854_CR3","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1002\/cncr.28722","volume":"120","author":"DS Dizon","year":"2014","unstructured":"Dizon DS, Mackay HJ, Thomas GM, etal. State of the science in cervical cancer: where we are today and where we need to go. Cancer, 2014, 120(15): 2282\u20132288","journal-title":"Cancer"},{"key":"1854_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-397918-6.00001-X","volume":"548","author":"Z Wang","year":"2014","unstructured":"Wang Z, Cole PA. Catalytic mechanisms and regulation of protein kinases. Methods Enzymol, 2014, 548:1\u201321","journal-title":"Methods Enzymol"},{"issue":"1","key":"1854_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(01)00561-4","volume":"170","author":"AH Schonthal","year":"2001","unstructured":"Schonthal AH. Role of serine\/threonine protein phosphatase 2A in cancer. Cancer Lett, 2001, 170(1): 1\u201313","journal-title":"Cancer Lett"},{"issue":"10","key":"1854_CR6","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1523\/JNEUROSCI.5174-09.2010","volume":"30","author":"LQ Zhu","year":"2010","unstructured":"Zhu LQ, Zheng HY, Peng CX, etal. Protein phosphatase 2A facilitates axonogenesis by dephosphorylating CRMP2. J Neurosci, 2010, 30(10): 3839\u20133848","journal-title":"J Neurosci"},{"issue":"7123","key":"1854_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature05351","volume":"445","author":"US Cho","year":"2007","unstructured":"Cho US, Xu W. Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature, 2007, 445(7123): 53\u201357","journal-title":"Nature"},{"issue":"1","key":"1854_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1128\/JVI.01381-10","volume":"85","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Mui MZ, Chan F, etal. Genetic analysis of B55alpha\/Cdc55 protein phosphatase 2A subunits: association with the adenovirus E4orf4 protein. J Virol, 2011,85(1): 286\u2013295","journal-title":"J Virol"},{"issue":"1","key":"1854_CR9","first-page":"1","volume":"1795","author":"PJ Eichhorn","year":"2009","unstructured":"Eichhorn PJ, Creyghton MP, Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta, 2009, 1795(1): 1\u201315","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"1854_CR10","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.bbadis.2014.06.032","volume":"1842","author":"I Cristobal","year":"2014","unstructured":"Cristobal I, Rincon R, Manso R, etal. Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation. Biochim Biophys Acta, 2014, 1842(9): 1823\u20131829","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"1854_CR11","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3892\/ol.2014.1866","volume":"7","author":"L Dong","year":"2014","unstructured":"Dong L, Zhu J, Wen X, etal. Involvement of SET in the Wnt signaling pathway and the development of human colorectal cancer. Oncol Lett, 2014, 7(4): 1203\u20131208","journal-title":"Oncol Lett"},{"issue":"25","key":"1854_CR12","doi-asserted-by":"publisher","first-page":"9157","DOI":"10.1073\/pnas.1317630111","volume":"111","author":"M Janghorban","year":"2014","unstructured":"Janghorban M, Farrell AS, Allen-Petersen BL, etal. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer. Proc Natl Acad Sci USA 2014, 111(25): 9157\u20139162","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1854_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/cgt.2014.18","volume":"21","author":"L Wei","year":"2014","unstructured":"Wei L, Qu W, Sun J, etal. Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin. Cancer Gene Ther, 2014, 21(5): 194\u2013199","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"1854_CR14","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1158\/1535-7163.MCT-13-0800","volume":"13","author":"XL Bai","year":"2014","unstructured":"Bai XL, Zhang Q, Ye LY, etal. Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomas. Mol Cancer Ther, 2014, 13(8): 2062\u20132072","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"1854_CR15","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.bbamcr.2014.05.006","volume":"1843","author":"PP Ruvolo","year":"2014","unstructured":"Ruvolo PP, Ruvolo VR, Jacamo R, etal. The protein phosphatase 2A regulatory subunit B55alpha is a modulator of signaling and microRNA expression in acute myeloid leukemia cells. Biochim Biophys Acta, 2014, 1843(9): 1969\u20131977","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"1854_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/glia.22347","volume":"60","author":"XP Liu","year":"2012","unstructured":"Liu XP, Zheng HY, Qu M, etal. Upregulation of astrocytes protein phosphatase-2A stimulates astrocytes migration via inhibiting p38 MAPK in tg2576 mice. Glia, 2012, 60(9): 1279\u20131288","journal-title":"Glia"},{"issue":"11","key":"1854_CR17","doi-asserted-by":"publisher","first-page":"e27804","DOI":"10.1371\/journal.pone.0027804","volume":"6","author":"YQ Tong","year":"2011","unstructured":"Tong YQ, Liu B, Zheng HY, etal. BMI-1 autoantibody as a new potential biomarker for cervical carcinoma. PloS one, 2011,6(11): e27804","journal-title":"PloS one"},{"issue":"1","key":"1854_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/138920311795659443","volume":"12","author":"S Basu","year":"2011","unstructured":"Basu S. PP2A in the regulation of cell motility and invasion. Curr Protein Pept Sci, 2011, 12(1): 3\u201311","journal-title":"Curr Protein Pept Sci"},{"issue":"7","key":"1854_CR19","volume":"9","year":"2014","unstructured":"Li N, Yang L, Ou W, etal. Meta-analysis of EGFR tyrosine kinase inhibitors compared with chemotherapy as second-line treatment in pretreated advanced nonsmall cell lung cancer. PloS one, 2014,9(7): el02777","journal-title":"PloS one"},{"issue":"17","key":"1854_CR20","first-page":"30260","volume":"S1357-2725","author":"B Meeusen","year":"2017","unstructured":"Meeusen B, Janssens V. Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification. Int J Biochem Cell Biol, 2017, pii: S1357-2725(17)30260\u20131","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"1854_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.intimp.2010.05.014","volume":"10","author":"AM Hasan","year":"2010","unstructured":"Hasan AM, Mourtada-Maarabouni M, Hameed MS, etal. Phosphoinositide 3-kinase gamma mediates chemotactic responses of human eosinophils to platelet-activating factor. Int Immunopharmacol, 2010, 10(9): 1017\u20131021","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1854_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.yexcr.2014.06.022","volume":"328","author":"A Bera","year":"2014","unstructured":"Bera A, Das F, Ghosh-Choudhury N, etal. microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKbeta-mTORCl axis to regulate renal cancer cell invasion. Exp Cell Res, 2014, 328(1): 99\u2013127","journal-title":"Exp Cell Res"},{"issue":"7","key":"1854_CR23","first-page":"el02289","volume":"9","author":"JM Pavese","year":"2014","unstructured":"Pavese JM, Ogden IM, Voll EA, etal. Mitogen-activated protein kinase kinase4 (MAP2K4) promotes human prostate cancer metastasis. PLloS One, 2014,9(7): el02289","journal-title":"PLloS One"},{"issue":"35","key":"1854_CR24","doi-asserted-by":"publisher","first-page":"24102","DOI":"10.1074\/jbc.M114.593582","volume":"289","author":"GM Sizemore","year":"2014","unstructured":"Sizemore GM, Sizemore ST, Seachrist DD, etal. GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular regulated kinase 1\/2 (ERK1\/2). J Biol Chem, 2014, 289(35): 24102\u201324113.","journal-title":"J Biol Chem"},{"issue":"2","key":"1854_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.toxlet.2014.07.001","volume":"229","author":"A Ptak","year":"2014","unstructured":"Ptak A, Hoffmann M, Gruca I, etal. Bisphenol A induce ovarian cancer cell migration via the MAPK and PI3K\/Akt signalling pathways. Toxicol Lett, 2014, 229(2): 357\u2013365","journal-title":"Toxicol Lett"},{"key":"1854_CR26","first-page":"441","volume":"7","author":"ZS Yang","year":"2014","unstructured":"Yang ZS, Tang XJ, Guo XR, etal. Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration. Onco Targets Ther, 2014, 7:441\u2013446","journal-title":"Onco Targets Ther"},{"issue":"5","key":"1854_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/MPA.0b013e3182793fd7","volume":"42","author":"EG Gomes","year":"2013","unstructured":"Gomes EG, Connelly SF, Summy JM. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo. Pancreas, 2013, 42(5): 795\u2013806","journal-title":"Pancreas"},{"issue":"52","key":"1854_CR28","doi-asserted-by":"publisher","first-page":"36926","DOI":"10.1074\/jbc.M113.527564","volume":"288","author":"B Boivin","year":"2013","unstructured":"Boivin B, Chaudhary F, Dickinson BC, etal. Receptor protein-tyrosine phosphatase alpha regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility. J Biol Chem, 2013, 288(52): 36926\u201336935","journal-title":"J Biol Chem"},{"issue":"2","key":"1854_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3892\/or.2014.3266","volume":"32","author":"MY Wu","year":"2014","unstructured":"Wu MY, Xie X, Xu ZK, etal. PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt\/beta-catenin pathway by phosphorylation and degradation of beta-catenin. Oncol Rep, 2014, 32(2): 513\u2013522","journal-title":"Oncol Rep"},{"issue":"9","key":"1854_CR30","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1271\/bbb.130060","volume":"77","author":"TD Dung","year":"2013","unstructured":"Dung TD, Feng CC, Kuo WW, etal. Suppression of plasminogen activators and the MMP-2\/-9 pathway by a Zanthoxylum avicennae extract to inhibit the HA22T human hepatocellular carcinoma cell migration and invasion effects in vitro and in vivo via phosphatase 2A activation. Biosci Biotechnol Biochem, 2013, 77(9): 1814\u20131821","journal-title":"Biosci Biotechnol Biochem"},{"key":"1854_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ncomms1675","volume":"3","author":"G Li","year":"2012","unstructured":"Li G, Ji XD, Gao H, etal. EphB3 suppresses nonsmall-cell lung cancer metastasis via a PP2A\/ RACKl\/Akt signalling complex. Nat Commun, 2012,3:667","journal-title":"Nat Commun"},{"issue":"10","key":"1854_CR32","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/onc.2014.26","volume":"34","author":"O Gilan","year":"2014","unstructured":"Gilan O, Diesch J, Amalia M, etal. PR55alpha-containing protein phosphatase 2A complexes promote cancer cell migration and invasion through regulation of AP-1 transcriptional activity. Oncogene, 2014, 34(10): 1333\u20131339","journal-title":"Oncogene"},{"issue":"12","key":"1854_CR33","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.bbamcr.2012.09.004","volume":"1823","author":"MK Park","year":"2012","unstructured":"Park MK, Park Y, Shim J, etal. Novel involvement of leukotriene B(4) receptor 2 through ERK activation by PP2A down-regulation in leukotriene B(4)-induced keratin phosphorylation and reorganization of pancreatic cancer cells. Biochim Biophys Acta, 2012, 1823(12): 2120\u20132129","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"1854_CR34","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1038\/onc.2010.622","volume":"30","author":"CH Switzer","year":"2011","unstructured":"Switzer CH, Cheng RY, Vitek TM, etal. Targeting SET\/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy. Oncogene, 2011, 30(22): 2504\u20132513","journal-title":"Oncogene"},{"issue":"40","key":"1854_CR35","doi-asserted-by":"publisher","first-page":"29 712","DOI":"10.1074\/jbc.M703159200","volume":"282","author":"M Kong","year":"2007","unstructured":"Kong M, Bui TV, Ditsworth D, etal. The PP2A-associated protein alpha4 plays a critical role in the regulation of cell spreading and migration. J Biol Chem, 2007, 282(40): 29 712\u201329 720","journal-title":"J Biol Chem"},{"key":"1854_CR36","doi-asserted-by":"publisher","first-page":"S687","DOI":"10.1245\/s10434-014-3812-5","volume":"21","author":"YW Chang","year":"2014","unstructured":"Chang YW, Chen MW, Chiu CF, etal. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h\/PP2A\/NF-kappaB signaling in cervical cancer. Ann Surg Oncol, 2014,21 (Suppl 4): S687\u2013695","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1854_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","volume":"344","author":"X Sui","year":"2014","unstructured":"Sui X, Kong N, Ye L, etal. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett, 2014, 344(2): 174\u2013179","journal-title":"Cancer Lett"},{"issue":"4","key":"1854_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","volume":"1802","author":"EK Kim","year":"2010","unstructured":"Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta, 2010, 1802(4): 396\u2013405","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1854_CR39","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1158\/1541-7786.MCR-13-0587","volume":"12","author":"T Uekita","year":"2014","unstructured":"Uekita T, Fujii S, Miyazawa Y, etal. Oncogenic Ras\/ERK signaling activates CDCP1 to promote tumorinvasion and metastasis MCR, 2014,12(10): 1449\u20131459","journal-title":"MCR"},{"issue":"1","key":"1854_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ijc.28958","volume":"136","author":"B Hong","year":"2014","unstructured":"Hong B, Li H, Zhang M, etal. p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion. Int J Cancer, 2014,136(1): 34\u201343","journal-title":"Int J Cancer"},{"issue":"3","key":"1854_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jcp.10211","volume":"194","author":"T Lee","year":"2003","unstructured":"Lee T, Kim SJ, Sumpio BE. Role of PP2A in the regulation of p38 MAPK activation in bovine aortic endothelial cells exposed to cyclic strain. J Cell Physiol, 2003, 194(3): 349\u2013355","journal-title":"J Cell Physiol"},{"issue":"3","key":"1854_CR42","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3892\/ijo.2015.2814","volume":"46","author":"G Meng","year":"2015","unstructured":"Meng G, Wang W, Chai K, etal. Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways. Int J Oncol, 2015, 46(3): 1007\u20131017","journal-title":"Int J Oncol"},{"issue":"7","key":"1854_CR43","doi-asserted-by":"publisher","first-page":"e5920","DOI":"10.1590\/1414-431x20175920","volume":"50","author":"XD Gu","year":"2017","unstructured":"Gu XD, Xu LL, Zhao H, etal. Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway. Braz J Med Biol Res, 2017,50(7): e5920","journal-title":"Braz J Med Biol Res"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-018-1854-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-018-1854-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-018-1854-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T20:58:52Z","timestamp":1552597132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-018-1854-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1854"],"URL":"https:\/\/doi.org\/10.1007\/s11596-018-1854-9","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}